Beta blockers are not safe for everyone. Several medical conditions, from slow heart rhythms to asthma, make these medications potentially dangerous. Some people face absolute restrictions, while others need careful monitoring or a specific type of beta blocker. Here’s a breakdown of who should avoid them and why.
People With Slow Heart Rates or Heart Block
Beta blockers work partly by slowing the heart rate. If your heart already beats too slowly, adding a beta blocker can push it into dangerously low territory. A resting heart rate below 50 beats per minute is generally considered bradycardia, and rates below 40 bpm are classified as significant. Anyone with symptomatic bradycardia, meaning a slow heart rate that causes dizziness, fatigue, or fainting, should not take beta blockers.
Heart block is a related concern. This is a condition where electrical signals traveling from the upper to lower chambers of the heart are delayed or interrupted. First-degree heart block (a minor delay) is usually tolerable. But second-degree Mobitz type II block, advanced heart block, and third-degree (complete) heart block are all situations where beta blockers can worsen the electrical disruption and potentially cause the heart to stop beating effectively. People with sick sinus syndrome who don’t have a pacemaker also fall into this category.
People With Asthma
Asthma is one of the clearest reasons to avoid beta blockers, especially non-selective types like propranolol. These drugs block receptors in the lungs that help keep airways open. In someone with reactive airways, this can trigger severe bronchospasm, a sudden tightening of the muscles around the airways that makes breathing extremely difficult.
The picture is more nuanced with cardioselective beta blockers, which primarily target the heart rather than the lungs. A randomized trial of 19 adults with mild or moderate asthma found no increase in flare-ups during two weeks of bisoprolol use. Another study tracked 13 asthma patients taking nebivolol, a highly selective beta blocker, over 24 weeks and found no significant decline in lung function. Current guidelines support using cardioselective beta blockers in COPD when there’s a clear medical need, and emerging evidence suggests the same may apply in mild asthma when a highly selective agent like bisoprolol is used at the lowest effective dose. Still, this requires close supervision, and non-selective beta blockers remain off the table for anyone with asthma.
People in Decompensated Heart Failure or Shock
This one catches some people off guard, because beta blockers are actually a cornerstone of treatment for stable, chronic heart failure. The key word is “stable.” When heart failure is decompensated, meaning the heart is actively failing to pump enough blood and the body is in crisis, beta blockers make things worse. They reduce the heart’s pumping strength and rate at exactly the moment the body needs every bit of cardiac output it can get. Cardiogenic shock, where dangerously low blood pressure results from the heart’s inability to pump, is an absolute contraindication.
People With Raynaud’s or Peripheral Artery Disease
Beta blockers can reduce blood flow to the extremities by allowing blood vessels in the hands and feet to constrict unopposed. For someone with Raynaud’s phenomenon, a condition where fingers and toes turn white or blue in response to cold or stress, beta blockers can make episodes more frequent and severe. The mechanism involves increased activity at receptors on peripheral blood vessels that promote constriction, combined with reduced ability of those vessels to dilate.
Non-selective beta blockers carry the highest risk. Global pharmacovigilance data from the WHO identifies beta blockers as one of the drug classes most strongly linked to drug-induced Raynaud’s. People with peripheral artery disease, where narrowed arteries already limit blood flow to the legs, face similar risks of worsening symptoms like pain during walking or slow-healing wounds.
People With Certain Adrenal Tumors
Pheochromocytoma is a rare tumor of the adrenal glands that produces surges of adrenaline-like hormones. Giving a beta blocker to someone with an unblocked pheochromocytoma is dangerous because it removes the body’s ability to dilate blood vessels through beta receptors while leaving the constricting effects of adrenaline fully active. The result can be a hypertensive crisis, with blood pressure spiking to life-threatening levels. If beta blockers are needed, alpha-blocking medications must be started first. The exceptions are carvedilol and labetalol, which block both alpha and beta receptors simultaneously.
Pregnant Women (With Few Exceptions)
Most beta blockers pose risks during pregnancy. A large study comparing beta blocker-exposed pregnancies to unexposed ones found that exposed infants had a mean birth weight of 2,996 grams compared to 3,353 grams in the unexposed group. Low birth weight (under 2,500 grams) occurred in 21.5% of exposed babies versus 5.2% of unexposed babies. The odds of a baby being born small for gestational age were 2.6 times higher with any beta blocker exposure.
Among specific drugs, labetalol was associated with the lowest mean birth weight (2,926 grams) and the highest rate of low birth weight at 24.4%, followed by atenolol at 18%. Interestingly, metoprolol and propranolol did not show a significant association with small-for-gestational-age births. Beyond growth restriction, beta blockers can cause slow heart rate and low blood sugar in newborns. Despite these risks, labetalol remains one of the most commonly used medications for pregnancy-related high blood pressure because the alternatives carry their own dangers, and uncontrolled hypertension during pregnancy is itself a serious threat.
People With Diabetes Who Experience Low Blood Sugar
Beta blockers don’t cause low blood sugar on their own, but they can mask the warning signs your body normally uses to alert you. When blood sugar drops, the body releases a surge of stress hormones that speed up the heart, cause trembling, and trigger sweating. Beta blockers suppress the rapid heartbeat and trembling, which are often the first signals a person with diabetes notices. This means blood sugar can fall to dangerous levels before you realize anything is wrong.
The masking effect extends beyond blood sugar. The same stress-hormone response kicks in during low blood pressure episodes, and beta blockers can hide those symptoms too, making it harder for the body to recover. For people with diabetes who use insulin or medications that lower blood sugar, this is an important conversation to have before starting a beta blocker. More frequent blood sugar monitoring can help offset the risk.
People Taking Certain Calcium Channel Blockers
Combining beta blockers with the calcium channel blockers diltiazem or verapamil is considered an absolute contraindication. Both drug classes slow electrical conduction through the heart, and together they can cause severe bradycardia, dangerous drops in blood pressure, or complete heart block. A clinical syndrome called BRASH (bradycardia, renal failure, AV nodal blockade, shock, and hyperkalemia) has been described in patients on these combinations, particularly those with underlying kidney problems. In one published case, a 75-year-old woman on both medications arrived at the hospital with a heart rate of 38, dangerously low blood pressure, and acute kidney failure, requiring intensive care and preparation for emergency pacing.
Other types of calcium channel blockers, like amlodipine, do not carry the same risk and are often safely combined with beta blockers.
People With Depression or Sleep Problems
Beta blockers that dissolve easily in fat, called lipophilic beta blockers, can cross from the bloodstream into the brain. Propranolol is the most common example. Once in the brain, these drugs may contribute to depressive symptoms, sleep disturbances, and vivid dreams. Research on diabetic patients undergoing dialysis found that lipophilic beta blockers were more strongly associated with depressive symptoms than water-soluble (hydrophilic) alternatives. This creates a particular irony with propranolol, which is widely prescribed for anxiety: the same property that lets it calm anxiety symptoms may also increase the risk of depression over time. If you have a history of depression, a hydrophilic beta blocker like atenolol may be a better fit.
People With Psoriasis
Psoriasis is listed as an absolute contraindication for beta blockers. These medications can trigger new psoriasis or worsen existing disease. If you have psoriasis and need blood pressure or heart rate management, alternative drug classes are typically preferred.
Why You Should Never Stop Abruptly
Even if you fall into one of the groups above, stopping a beta blocker suddenly is dangerous. Your body adapts to the drug by becoming more sensitive to adrenaline, so when the drug is removed all at once, the resulting adrenaline surge can cause rebound high blood pressure, rapid heart rate, and in people with coronary artery disease, potentially a heart attack. Tapering off gradually over one to two weeks gives the body time to readjust. This applies regardless of the reason for stopping.